from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1070c/echA8

LFCtreatmentdescriptionclass of inhibitor

-1.699

Amikacinug/mL Amikacintranslation

-0.593

Cap5-10ug/mL Capreomycintranslation

-1.872

Rox10-50 ug/mL Roxithromycintranslation

0.190

SM2-5 ug/mL Streptomycintranslation

-2.663

Tet5-10 ug/mL Tetracyclinetranslation

-1.337

Rif0.2-5ug/mL Rifampicintranscription

-0.817

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.711

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.546

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.757

CPZ10-50 ug/mL Chlorpromazinerespiration

0.484

Clofazimine10-13 ug/mL Clofaziminerespiration

0.572

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.930

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.980

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.047

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.786

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.423

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.300

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.646

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.133

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.173

KCN5-20 ug/mL Potassium cyaniderespiration

1.204

NaN30.2-2 mM Sodium aziderespiration

0.714

Nigericin50 uM Nigericinrespiration

0.089

TRC10-150 ug/mL Triclosanrespiration

-0.435

TRZ10-25 ug/mL Thioridazinerespiration

-2.039

Valinomycin0.5-10 uM Valinomycinrespiration

0.625

ZnSO42 mM ZnSO4respiration

-0.270

menadione6-10 ug/mL Menadionerespiration

-0.387

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.390

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.206

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.624

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.229

NRP_1Non-replicating persistence stage 1dosRassociated

0.315

Amp0.2mg/mL AmpicillincellWall

0.099

Cephalexin20-100 ug/mL CephalexincellWall

0.871

Cerulenin0.32-5 ug/mL CerulenincellWall

0.691

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.157

EMB10-20 ug/mL EthambutolcellWall

0.602

Eta12-40 ug/mL EthionamidecellWall

0.221

INH0.2-0.4 ug/mL IsoniazidcellWall

0.575

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.047

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.662

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.169

BZA0.12 mg/mL BenzamidearomaticAmides

0.400

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.591

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.231

H2O24 mM hydrogen peroxideDNAdamaging

0.929

Levo10 ug/mL LevofloxacinDNAdamaging

0.346

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.980

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.737

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.140

UVUV-irradiationDNAdamaging

-1.235

ARP41-4 ug/mL Antitubercular compound ARP4?

0.408

Antimycin12.5-50 ug/mL Antimycin A?

0.528

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.985

PA_110-50 ug/mL Antitubercular compound PA-1?

1.004

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.056

PA8240.2-2 ug/mL PA-824?

-0.750

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.393

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.157

Verapamil50 uM Verapamil?

-0.051

mercaptoethanol2 mM 2-Mercaptoethanol?

0.673

methoxatin10-20 ug/mL Methoxatin?